Neupro 3 mg/24h
rotigotine · PATCH, EXTENDED RELEASE · UCB, Inc.
No Recall History
Plain English
Neupro is a patch, extended release containing rotigotine at 3 mg/24h, taken transdermal. Manufactured by UCB, Inc..
Key Facts
- Brand Name
- Neupro
- Generic Name
- rotigotine
- NDC Code (Product)
50474-803- Manufacturer
- UCB, Inc.
- Strength
- 3 mg/24h
- Dosage Form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing Status
- Application #
- NDA021829
- Drug Class
- Nonergot Dopamine Agonist [EPC]
- Marketing Start
- 04/02/2012
Recall History
No Recall HistoryFrequently Asked Questions
What is Neupro used for?
Neupro contains rotigotine. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.
Is Neupro a controlled substance?
Neupro is not classified as a controlled substance by the DEA.
What is the generic name for Neupro?
The generic name for Neupro is rotigotine. There are no other listed brand versions of rotigotine.
What is the NDC code for Neupro 3 mg/24h?
The NDC (National Drug Code) for Neupro 3 mg/24h is 50474-803, listed by UCB, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)